|
|
| Countries covered: Global This report analyzes the Global market for Epigenetics in US$ Million by the following Application Areas: Drug Discovery, Diagnostics, and Others. Annual forecasts are provided for the period 2006 through 2015. The report profiles 39 companies including many key and niche players worldwide such as Celgene Corporation, CellCentric Ltd., CellCentric Ltd., Epigentek Group, Inc., Genpathway, Inc., Merck & Co., Inc., MGI Pharma, Inc., Millipore Corporation, OncoMethylome Sciences S.A., and Orion Genomics. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources. Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location. The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report. Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher. |
More Global Drug Discovery Reports
Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 5th Edition by
Kalorama Information
The drug discovery process is long, arduous and costly, which has driven outsourcing in this field. The first phase is discovery of a lead compound, ...
Non-Alcoholic Steatohepatitis Global Clinical Trials Review, H1, 2012 by
GlobalData
Non-Alcoholic Steatohepatitis Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Non-Alcoholic Steatohepatitis Global Clinical Trials Review, H1, 2012 provides data on the Non-Alcoholic Steatohepatitis ...
Tachycardia (Tachyarrhythmias) Global Clinical Trials Review, H1, 2012 by
GlobalData
Tachycardia (Tachyarrhythmias) Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Tachycardia (Tachyarrhythmias) Global Clinical Trials Review, H1, 2012 provides data on the Tachycardia (Tachyarrhythmias) ...
Restless Legs Syndrome Global Clinical Trials Review, H1, 2012 by
GlobalData
Restless Legs Syndrome Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Restless Legs Syndrome Global Clinical Trials Review, H1, 2012 provides data on the ...
Lung Injury Global Clinical Trials Review, H1, 2012 by
GlobalData
Lung Injury Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Lung Injury Global Clinical Trials Review, H1, 2012 provides data on the Lung Injury ...
See all reports like this >>
Related Markets
Drug Discovery Reports
- Biosensors - A Global Market Overview
- Nucleic Acid Therapies in Oncology Drug Pipeline Update 2012
- Stem Cells: Worldwide Markets for Transplantation and Cord Blood Banking (Projections for Stem Cell Use in Cancer, Alzheimer’s, Diabetes, Arthritis and Other Diseases)
- Synthetic Biology: Emerging Global Markets
- Biomarkers in Drug Discovery - Earlier Usage of Biomarkers in Optimization Stage to Reduce Drug Attrition Rate Significantly
